AU8547691A - Protein sequence-specific oligonucleotide sequences - Google Patents

Protein sequence-specific oligonucleotide sequences

Info

Publication number
AU8547691A
AU8547691A AU85476/91A AU8547691A AU8547691A AU 8547691 A AU8547691 A AU 8547691A AU 85476/91 A AU85476/91 A AU 85476/91A AU 8547691 A AU8547691 A AU 8547691A AU 8547691 A AU8547691 A AU 8547691A
Authority
AU
Australia
Prior art keywords
protein sequence
oligonucleotide sequences
specific oligonucleotide
sequences
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85476/91A
Inventor
Thomas Keith Blackwell
Harold Martin Weintraub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Research Center filed Critical Fred Hutchinson Cancer Research Center
Publication of AU8547691A publication Critical patent/AU8547691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
AU85476/91A 1990-09-21 1991-09-18 Protein sequence-specific oligonucleotide sequences Abandoned AU8547691A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58676990A 1990-09-21 1990-09-21
US586769 1990-09-21

Publications (1)

Publication Number Publication Date
AU8547691A true AU8547691A (en) 1992-04-15

Family

ID=24347046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85476/91A Abandoned AU8547691A (en) 1990-09-21 1991-09-18 Protein sequence-specific oligonucleotide sequences

Country Status (4)

Country Link
EP (1) EP0549692A4 (en)
JP (1) JPH06503715A (en)
AU (1) AU8547691A (en)
WO (1) WO1992005285A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668264A (en) * 1990-06-11 1997-09-16 Nexstar Pharmaceuticals, Inc. High affinity PDGF nucleic acid ligands
US5707796A (en) * 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
US6395888B1 (en) 1996-02-01 2002-05-28 Gilead Sciences, Inc. High affinity nucleic acid ligands of complement system proteins
US5789163A (en) * 1990-06-11 1998-08-04 Nexstar Pharmaceuticals, Inc. Enzyme linked oligonucleotide assays (ELONAS)
US5674685A (en) * 1990-06-11 1997-10-07 Nexstar Pharmaceuticals, Inc. High affinity PDGF nucleic acid ligands
DE69128350T2 (en) 1990-06-11 1998-03-26 Nexstar Pharmaceuticals Inc NUCLEIC ACID LIGANDS
US5840867A (en) * 1991-02-21 1998-11-24 Gilead Sciences, Inc. Aptamer analogs specific for biomolecules
WO1993004204A1 (en) * 1991-08-23 1993-03-04 Isis Pharmaceuticals, Inc. Synthetic unrandomization of oligomer fragments
US5747253A (en) * 1991-08-23 1998-05-05 Isis Pharmaceuticals, Inc. Combinatorial oligomer immunoabsorbant screening assay for transcription factors and other biomolecule binding
WO1995016788A1 (en) * 1993-12-17 1995-06-22 Cubicciotti Roger S Nucleotide-directed assembly of bimolecular and multimolecular drugs and devices
US5723594A (en) * 1995-06-07 1998-03-03 Nexstar Pharmaceuticals, Inc. High affinity PDGF nucleic acid ligands
US6699843B2 (en) 1995-06-07 2004-03-02 Gilead Sciences, Inc. Method for treatment of tumors using nucleic acid ligands to PDGF
WO2001071043A1 (en) 2000-03-22 2001-09-27 Quantum Dot Corporation Loop probe hybridization assay for polynucleotide analysis
DE60137953D1 (en) 2000-10-06 2009-04-23 Life Technologies Corp CELLS WITH SPECTRAL SIGNATURE AND METHOD FOR THEIR PRODUCTION AND USE
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
US6989452B2 (en) 2001-05-31 2006-01-24 Medarex, Inc. Disulfide prodrugs and linkers and stabilizers useful therefor
US8030465B2 (en) 2001-06-29 2011-10-04 Medimolecular Pty Ltd Nucleic acid ligands to complex targets
EP1425408A4 (en) 2001-08-17 2004-11-10 Neose Technologies Inc Chemo-enzymatic synthesis of sialylated oligosaccharides
AU2003213729A1 (en) 2002-03-05 2003-09-22 Board Of Regents, The University Of Texas System Biospecific contrast agents
WO2003078623A1 (en) 2002-03-19 2003-09-25 Fujitsu Limited Functional molecule and process for producing the same
CA2492463A1 (en) 2002-07-25 2004-02-05 Archemix Corporation Regulated aptamer therapeutics
US9303262B2 (en) 2002-09-17 2016-04-05 Archemix Llc Methods for identifying aptamer regulators
US8853376B2 (en) 2002-11-21 2014-10-07 Archemix Llc Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US10100316B2 (en) 2002-11-21 2018-10-16 Archemix Llc Aptamers comprising CPG motifs
WO2004113495A2 (en) 2003-05-23 2004-12-29 The President And Fellows Of Harvard College Rna-based transcriptional regulators
US7803624B2 (en) 2003-09-30 2010-09-28 Cytyc Corporation Automated cytological sample classification
US7803931B2 (en) 2004-02-12 2010-09-28 Archemix Corp. Aptamer therapeutics useful in the treatment of complement-related disorders
ES2808955T3 (en) 2004-02-12 2021-03-02 Archemix Llc Aptamer-based therapeutic agents useful in the treatment of complement-related disorders
US7579450B2 (en) 2004-04-26 2009-08-25 Archemix Corp. Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
US7659091B2 (en) 2004-09-21 2010-02-09 Nourheart, Inc. Diagnostic marker
US7662571B2 (en) 2005-07-14 2010-02-16 Nourheart Inc. Mitochondrial markers of ischemia
CA2623652C (en) 2005-09-26 2013-11-26 Medarex, Inc. Antibody-drug conjugates and methods of use
US20080008694A1 (en) 2006-07-05 2008-01-10 Elgebaly Salwa A Methods to prevent and treat diseases
US8501912B2 (en) 2007-12-03 2013-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Filipil compositions and methods for treating cancer
US20110229498A1 (en) 2008-05-08 2011-09-22 The Johns Hopkins University Compositions and methods for modulating an immune response
US20100291706A1 (en) 2009-05-15 2010-11-18 Millipore Corporation Dye conjugates and methods of use
US20150086584A1 (en) 2012-03-22 2015-03-26 University Of Miami Multi-specific binding agents
DE102014114834A1 (en) 2014-10-13 2016-04-14 Centrum Für Angewandte Nanotechnologie (Can) Gmbh Nanoparticle-containing polymer micelles in non-aqueous solution, methods for their preparation and their application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772691A (en) * 1985-06-05 1988-09-20 The Medical College Of Wisconsin, Inc. Chemically cleavable nucleotides
JP2749042B2 (en) * 1986-01-09 1998-05-13 マサチユ−セツツ インスチチユ−ト オブ テクノロジ− Nuclear factors involved in transcriptional regulation
DE69128350T2 (en) * 1990-06-11 1998-03-26 Nexstar Pharmaceuticals Inc NUCLEIC ACID LIGANDS

Also Published As

Publication number Publication date
EP0549692A4 (en) 1993-08-25
EP0549692A1 (en) 1993-07-07
WO1992005285A1 (en) 1992-04-02
JPH06503715A (en) 1994-04-28

Similar Documents

Publication Publication Date Title
AU8547691A (en) Protein sequence-specific oligonucleotide sequences
AU685356B2 (en) Interferon solution
AU5160796A (en) Dual action syringe
AUPN416295A0 (en) Moulded article
AP9300538A0 (en) New dna sequences
AU2317095A (en) Dna sequences
AU8260491A (en) Dna sequencing
AU4556589A (en) Extended nucleotide sequences
AU675373B2 (en) Monoaminoalkyl-terminated organopolysiloxanes
AU7211596A (en) Food dressing
AU8284991A (en) Neurofibromatosis gene
AU3979395A (en) DNA sequences and their use
GB9526218D0 (en) DNA Sequences
AU2720392A (en) Moulded clip
AU6736496A (en) Food dressing
AU6524196A (en) Moulded article
AUPO060996A0 (en) Sexing gene
AU2614497A (en) Medical article
AU2312795A (en) Article cleaning
AU5582194A (en) Virulence-specific bacterial dna sequence
GB9624266D0 (en) Improved cutlery
AU2387292A (en) Antisense oligonucleotides
AU1617495A (en) Novel protein PHBP-70
AU2961792A (en) Virulence-specific bacterial dna sequence
AU7905191A (en) Clothes-hanger